Omalizumab Weight-Based Dosing Efficacy Trial
NCT06943534
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Allergies
Food Allergy
Interventions
DRUG:
5mg/kg omalizumab injection
DRUG:
15mg/kg omalizumab injection
Sponsor
Massachusetts General Hospital